Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

188.14 -1.71 (-0.90%)
Streaming Delayed Price Updated: 1:44 PM EDT, Jun 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers
Looking back on drug development inputs & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Charles River Laborato... 
Via StockStory
Topics Economy
News headline image
The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call
Charles River Laboratories’ first quarter results reflected a mix of ongoing business transformation and operational adjustments. Management pointed to the i... 
Via StockStory
Topics Earnings
Charles River Laboratories (NYSE:CRL) Beats Q1 Estimates, Reaffirms Guidance ↗
Via Chartmill
News headline image
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi... 
Via StockStory
Topics Economy
News headline image
Charles River Laboratories International Q1 Earnings Call Highlights ↗
Charles River Laboratories International (NYSE:CRL) reported first-quarter 2026 results that management said were in line to slightly ahead of its prior outlook, while reaffirming its full-year organic... 
Via MarketBeat
Topics Earnings Economy
News headline image
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results ↗
Charles River Laboratories (NYSE: CRL) beat Q1 earnings estimates but lowered its FY2026 forecast. Analysts maintain positive outlook with raised price targets. 
Via Benzinga
News headline image
CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion
Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.2% year on y... 
Via StockStory
Topics Artificial Intelligence
News headline image
Charles River (CRL) Q1 2026 Earnings Transcript ↗
Charles River (CRL) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations
Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.2% year on ... 
Via StockStory
News headline image
Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect
Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings this Thursday before market hours. Here’s what investors should know. C... 
Via StockStory
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such a... 
Via StockStory
News headline image
1 S&P 500 Stock to Own for Decades and 2 We Find Risky
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener... 
Via StockStory
Topics Economy
News headline image
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci... 
Via StockStory
Topics Government Stocks
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Monday. ↗
Via Chartmill
Monday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Economy Government Stocks
News headline image
1 Value Stock on Our Buy List and 2 We Turn Down
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
Movers and shakers in today's after-hours session for S&P500 stocks? ↗
Via Chartmill
Which stocks are moving after the closing bell on Monday? ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
3 Reasons CRL is Risky and 1 Stock to Buy Instead
Over the past six months, Charles River Laboratories has been a great trade, beating the S&P 500 by 7.5%. Its stock price has climbed to $168.91, representin... 
Via StockStory
Topics Stocks
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack
Via StockStory
News headline image
Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.